CUG2 Activators represent a diverse group of chemical compounds that play a pivotal role in enhancing the functional activity of CUG2, a protein with multifaceted cellular functions. These activators operate through a range of well-defined mechanisms, each tailored to indirectly boost CUG2's activity. For instance, Forskolin elevates intracellular cAMP levels, subsequently activating protein kinase A (PKA), a key player in CUG2-related cellular processes.
Meanwhile, Genistein inhibits tyrosine kinases, reducing competition from tyrosine kinase signaling and allowing CUG2 pathways to flourish, enhancing its functional activity. This group also includes compounds like Sphingosine-1-phosphate and Thapsigargin, which modulate lipid and calcium signaling, respectively, indirectly potentiating cellular processes where CUG2 is involved, without affecting its expression or direct activation. PMA, Epigallocatechin, LY294002, Wortmannin, SB203580, U0126, A23187, and Staurosporine all contribute to CUG2 activation by either promoting CUG2-related pathways or reducing competitive signaling, ensuring that CUG2's vital functions are enhanced.
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
While a broad-spectrum protein kinase inhibitor, Staurosporine can selectively activate CUG2 pathways by lifting the inhibition exerted by specific kinases. |